JPMORGAN CHASE & CO - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 43 filers reported holding EDGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$31,000
-99.1%
25,766
-93.1%
0.00%
-100.0%
Q4 2017$3,475,000
-14.5%
370,960
-2.1%
0.00%0.0%
Q3 2017$4,063,000
+237.7%
379,075
+223.4%
0.00%
Q2 2017$1,203,000
+9.5%
117,225
-2.9%
0.00%
Q1 2017$1,099,000
-31.3%
120,675
-5.7%
0.00%
Q4 2016$1,599,000
+22.5%
127,946
+2.1%
0.00%
Q3 2016$1,305,000
+10.4%
125,375
+7.2%
0.00%
Q2 2016$1,182,000
+6.6%
116,925
-3.5%
0.00%
Q1 2016$1,109,000
-23.0%
121,150
+5.1%
0.00%
Q4 2015$1,441,000115,2750.00%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$24,058,00016.90%
VHCP Management II, LLC 1,933,582$19,839,0007.92%
ACUTA CAPITAL PARTNERS, LLC 1,504,612$15,437,0004.32%
Opaleye Management Inc. 130,000$1,334,0000.56%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,539,0000.26%
DAFNA Capital Management LLC 19,400$199,0000.14%
REGENTATLANTIC CAPITAL LLC 134,900$1,384,0000.13%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 14,400$148,0000.10%
TFS CAPITAL LLC 20,080$206,0000.08%
EAGLE ASSET MANAGEMENT INC 901,359$9,247,0000.06%
View complete list of EDGE THERAPEUTICS INC shareholders